1 / 10

You are a Rx company Marketing Executive

You are a Rx company Marketing Executive How does incorporating scientific education tools into your promo mix help you?. Major dynamics that drive Rx marketing decisions?. From Rx company Marketing Executive point of view:. What Physicians Want!. A Publicis Selling Solutions White Paper

amy
Download Presentation

You are a Rx company Marketing Executive

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. You are a Rx company Marketing Executive How does incorporating scientific education tools into your promo mix help you?

  2. Major dynamics that drive Rx marketing decisions?

  3. From Rx company Marketing Executive point of view:

  4. What Physicians Want! A Publicis Selling Solutions White Paper Results of a Sermo “Hot Spot” Physician Survey Source: NEW YORK, Feb. 25, 2009 (GLOBE NEWSWIRE) --- http://pharmalive.com/news/index.cfm?articleID=607458&categoryid=9&newsletter=1

  5. A wide variety of medical specialists completed the survey; the top five included: Internal Medicine 20.2% Family Medicine 15.4% Psychiatry 9.6% Pediatrics 9.1% Emergency Medicine 5.8%Other respondents included:Allergy and Immunology (1.0%), Anesthesiology (1.9%), Cardiology (0.5%), Critical Care (0.5%), Dermatology (1.0%), Endocrinology (1.0%), Gastroenterology (2.4%), Geriatrics (1.0%), Gynecology (1.0%), Hematology/Oncology (2.9%), Infectious Disease (1.0), Meds/Peds (2.9%), Nephrology (1.4%), Orthopedics (0.5%), Otolaryngology (1.9%), Pain Medicine (0.5%), Pathology (1.0%), Physiatry (1.0%), Pulmonology (0.5%), Radiation Oncology (1.9%), Radiology (1.9%), Rheumatology (1.4%), Other (3.8%; included General Surgery, Geriatric Psychiatry, Hospital Medicine, Interventional Radiology, and Surgery)

  6. Evidence based medicine means pharma companies will strive to provide “independent 3rd party” informationthat will help physicians make optimal decisions for their patients One of major conclusions was:

  7. Further… according to a report published by PricewaterhouseCoopers LLP (PwC) *Smaller, Refocused Sales-force Will Enable Pharma Companies to Create Greater Value for PatientsSmaller sales-force also means pharma companies need to provide their sales-force withstrong tools* “The current role of the pharmaceutical industry's sales and marketing workforce will be replaced by a new model over the next ten years as the industry shifts from a mass-market to a target-market approach that will drive revenue growth in the industry and create value for patients..”

  8. What Med Reps Need! • Customized value-added solutions • Useful and User-friendly for doctors • Easy to handle for reps

  9. What Doctors want/Med Reps Need/Business RequiresStrong tools“independent 3rd party” Scientific Tools

  10. Dynamic Matrix Laws, Regulations R & D, Business Strategies

More Related